Del Mar, CA, United States of America

Douglas R Savage

USPTO Granted Patents = 31 

 

Average Co-Inventor Count = 2.8

ph-index = 15

Forward Citations = 1,550(Granted Patents)


Location History:

  • San Diego, CA (US) (2002)
  • Del Mar, CA (US) (1993 - 2019)

Company Filing History:


Years Active: 1993-2019

Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: **Douglas R Savage: Innovator in Drug Delivery Technologies**

Introduction

Douglas R Savage, based in Del Mar, California, is a trailblazing inventor with an impressive portfolio of 31 patents to his name. His contributions to the field of medical devices, particularly in drug delivery systems, have significantly impacted patient care and treatment methodologies.

Latest Patents

Among his latest innovations is the "Drug delivery endovascular stent and method of use." This patent describes an advancement in drug-eluting stents. The invention focuses on roughening the surface of a metal stent to achieve a surface roughness of at least 20 μin (0.5 μm) and a range of 300-700 μin (7.5-17.5 μm). The unique feature of this stent is its polymer-free coating with a limus drug, applied at a thickness surpassing the roughness of the stent surface. This advancement aims to enhance the effectiveness of drug delivery in vascular applications.

Career Highlights

Throughout his career, Douglas R Savage has worked with notable companies such as Biosensors International Group, Ltd. and Sendx Medical, Inc. His role in these organizations has allowed him to apply his innovative ideas and solidify his reputation in the biomedical field.

Collaborations

Savage has collaborated with esteemed colleagues, including Ronald E Betts and John E Shulze, to further advance the technology underlying medical devices. Their teamwork has contributed to the development of cutting-edge solutions that address critical healthcare needs.

Conclusion

Douglas R Savage continues to be a prominent figure in medical innovation. His groundbreaking patents, particularly in drug delivery systems, underline his commitment to improving healthcare outcomes. As he progresses in his career, his contributions promise to remain influential in the ongoing evolution of medical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…